Arianna Lark
Affiliations: | 2017- | Pharmacology and Toxicology | Virginia Commonwealth University, Richmond, VA, United States |
Google:
"Arianna Lark"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lark ARS, Nass SR, Hahn YK, et al. (2024) HIV-1 Tat and morphine interactions dynamically shift striatal monoamine levels and exploratory behaviors over time. Journal of Neurochemistry |
| Lark ARS, Silva LK, Nass SR, et al. (2022) Progressive Degeneration and Adaptive Excitability in Dopamine D1 and D2 Receptor-Expressing Striatal Neurons Exposed to HIV-1 Tat and Morphine. Cellular and Molecular Neurobiology |
| McLane VD, Lark ARS, Nass SR, et al. (2022) HIV-1 Tat reduces apical dendritic spine density throughout the trisynaptic pathway in the hippocampus of male transgenic mice. Neuroscience Letters. 782: 136688 |
| Yarotskyy V, Lark ARS, Nass SR, et al. (2022) Chloride channels with CLC-1-like properties differentially regulate the excitability of dopamine receptor D1- and D2-expressing striatal medium spiny neurons. American Journal of Physiology. Cell Physiology |
| Nass SR, Lark ARS, Hahn YK, et al. (2021) HIV-1 Tat and morphine decrease murine inter-male social interactions and associated oxytocin levels in the prefrontal cortex, amygdala, and hypothalamic paraventricular nucleus. Hormones and Behavior. 133: 105008 |
| Marks WD, Paris JJ, Barbour AJ, et al. (2021) HIV-1 Tat and morphine differentially disrupt pyramidal cell structure and function and spatial learning in hippocampal area CA1: Continuous versus interrupted morphine exposure. Eneuro |